Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)
מצבים רפואיים
Myelofibrosis (PMF) · Post Essential Thrombocythemia Myelofibrosis (ET-MF) · Post Polycythemia Vera Related Myelofibrosis (PV-MF)
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Moffitt Cancer Center, Tampa, Florida, United States
Contact: Principal Investigator (Andrew Kuykendall, MD)Emory University, Atlanta, Georgia, United States
Contact: Principal Investigator (Anthony Hunter, MD)Roswell Park Cancer Institute, Buffalo, New York, United States
Contact: Principal Investigator (Eunice Wang, MD)Ruttenberg Treatment Center, New York, New York, United States
Contact: Principal Investigator (Marina Kremyanskaya)Memorial Sloan Kettering Cancer Center, New York, New York, United States
Contact: Principal Investigator (Brian Chernak, MD)NewYork-Presbyterian/Weill Cornell Medical Center, New York, New York, United States
Contact: Principal Investigator (Ghaith Abu-Zeinah, MD)Wake Forest Baptist Health Comprehensive Cancer Center, Winston-Salem, North Carolina, United States
Contact: Principal Investigator (Rupali Bhave, MD)The Cleveland Clinic Foundation, Cleveland, Ohio, United States
Contact: Principal Investigator (Aaron Gerds, MD)The Ohio State University, Columbus, Ohio, United States
Contact: Principal Investigator (Shivani Handa, MD)
מובילי המחקר
Marina Kremyanskaya, PhD, MD
Study Chair
Icahn School of Medicine at Mount Sinai
Aaron Gerds, MD, MS
Study Chair
Cleveland Clinic Taussig Cancer Institute